コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and persistently unpolarized nonmuscle MIIA (myosin-IIA).
2 n uropod formation, and in the regulation of myosin IIa.
3 l synapses are active processes dependent on myosin IIA.
4 K cells, were constitutively associated with myosin IIA.
5 xin A2, the tumor-suppressor protein p53 and myosin IIA.
6 f the regulatory light chain associated with myosin IIA.
7 ered in a screen for inhibitors of nonmuscle myosin IIA.
8 ication of myosin (Myo) XVIIIA and nonmuscle myosin IIA.
9 eric interactions of SERT, specifically with myosin IIA.
10 sin- (HMM-) like fragment of human nonmuscle myosin IIA.
11 Ks and preplatelet fragments, which requires myosin IIA.
12 ivation of a pathway involving Vav, Rac, and myosin IIA.
13 or the phosphorylation of granule-associated myosin IIA.
14 ractions depend on the activity of nonmuscle myosin IIA.
15 ctin, and the major motor isoform, nonmuscle myosin-IIA.
16 ion compared with cells expressing wild-type myosin-IIA.
17 ional motility via a direct interaction with myosin-IIA.
18 ffecting the assembly of myosin-IIB, but not myosin-IIA.
19 e, appears to be similar to rabbit nonmuscle myosin-IIA.
20 anism for mediating the binding of S100A4 to myosin-IIA.
21 arcinoma cell motility via interactions with myosin-IIA.
23 ite and is recycled by binding to non-muscle myosin IIA, a motor protein, via the cytoplasmic tail (C
24 elated macrothrombocytopenias, MYH9, encodes myosin-IIA, a protein that enables morphogenesis in dive
25 Drugs inhibiting actin polymerization or myosin IIA activation prevented nanotube formation and v
26 ing asymmetric self-renewal and constitutive myosin-IIA activation promoting cytokine-triggered diffe
28 on both their filamentous actin content and myosin IIA activity, although the relative contribution
32 vivo, disruption of microtubules or loss of myosin IIA and B resulted in loss of tight junction-medi
33 ables, which were also determined to contain myosin IIA and exhibit additional characteristics of pur
34 primordium and observed interactions between myosin IIA and F-actin in cells encapsulated in collagen
38 L are, in part, related to a deregulation of myosin IIA and IIB expression leading to both a defect i
43 d and what role they play in cell migration, myosin IIA and IIB were examined during wound healing by
45 Arp2/3 disruption depleted junctions of both myosin IIA and IIB, suggesting that dynamic actin assemb
46 s the interaction of C2GnT-M with non-muscle myosin IIA and its transportation to the endoplasmic ret
47 : the scattered meiotic chromosomes initiate myosin IIA and microfilament assemble in the vicinity of
48 icking BM stiffness contributes, through the myosin IIA and MKL1 pathways, to a more favorable in vit
50 orylation that correlates the recruitment of myosin IIA and myosin IIB into this spreading margin.
53 ls-as a prototypical adherent cell-nonmuscle myosin IIA and vimentin are just two of the cytoskeletal
54 This effect occurs only in the presence of myosin-IIA and implies that myosin-IIA influences thromb
59 BMMs form unstable protrusions, overassemble myosin-IIA, and exhibit altered colony-stimulating facto
60 ulted in opposing migration phenotypes, with myosin IIA- and IIB-depleted cells exhibiting higher and
61 o show that the mechanism requires localized myosin-IIA- and alpha5beta1 integrin/fibronectin-mediate
62 unctional experiments, the microinjection of myosin IIA antibody disrupts meiotic maturation to metap
63 The interactions between Myosin VIIa and Myosin IIa are conserved in the mammalian cochlea and in
66 rvations are consistent with mts1 regulating myosin IIA assembly by monomer sequestration and suggest
71 agonism results from transient enrichment of myosin IIA at the cell front, which disrupts the back-to
72 ator of myosin II assembly, colocalizes with myosin IIA at the leading edge of cancer cells, suggesti
73 selective aggregation of myosin IIB but not myosin IIA at the region of parasite attachment, as asse
75 l mechanism for myosin II function, in which myosin IIA can act as a single-molecule actin motor, cla
76 ion-dependent stabilization of lamin-A,C and myosin-IIA can suitably couple nuclear and cell morpholo
77 s contained Plectin 1, Filamin A, non-muscle myosin IIA, clathrin, alpha-actinin, vimentin, actin, ca
78 in myosin V, smooth muscle myosin, nonmuscle myosin IIA, CMIIB, and DdMII, although the ADP affinity
80 tent of polymerization depend on the initial myosin-IIA concentration; however, mts1 had only a small
82 sruption of F-actin retrograde flow, but not myosin IIA contraction, arrested MC centralization and i
92 ore, we show that inhibition or silencing of myosin IIa enhances aggregation, suggesting that cytoske
97 eases the critical monomer concentration for myosin-IIA filament assembly by approximately 11-fold.
99 he effects of heavy chain phosphorylation on myosin-IIA filament formation and also examined mts1 bin
102 only weakly disassembled CK2-phosphorylated myosin-IIA filaments and weakly inhibited the assembly o
103 TFP to block S100A4-mediated disassembly of myosin-IIA filaments demonstrate that significant inhibi
104 in RhoA-GTP levels and triggered assembly of myosin-IIA filaments in THP1 cells, whereas the suppress
105 to filaments and promotes the disassembly of myosin-IIA filaments into monomers; however, mts1 has li
106 e that mts1 has a 9-fold higher affinity for myosin-IIA filaments than for myosin-IIB filaments.
109 ished F-actin flow in the lamella, displaced myosin IIA from the cell edge, and decreased FA turnover
111 that NK-cell cytotoxicity requires nonmuscle myosin IIA function and that granule-associated myosin I
112 ls showed that the degree of confinement and myosin IIA function, rather than integrin adhesion (as p
114 utations in the rod region disrupt nonmuscle myosin-IIA function, we examined the in vitro behavior o
115 ct link between S100A4 and the regulation of myosin-IIA function, we prepared an antibody to the S100
118 hrombin, Ca(2+), the integrin alphaIIbbeta3, myosin IIa, FXIIIa cross-linking, and platelet count all
119 hits-including Myh9, which encodes nonmuscle myosin IIa-have not been linked to tumor development, ye
122 Using Jurkat T cells expressing fluorescent myosin IIA heavy chain and F-tractin-a novel reporter fo
125 demonstrate that during osteoclastogenesis, myosin IIA heavy chain levels are temporarily suppressed
128 ned the EGF-dependent phosphorylation of the myosin-IIA heavy chain in human breast cancer cells.
130 demonstrate that CK2 phosphorylation of the myosin-IIA heavy chain protects against mts1-induced fil
131 n antibody to the S100A4 binding site on the myosin-IIA heavy chain that has comparable effects on my
132 that mts1 binds to residues 1909-1924 of the myosin-IIA heavy chain, which is near the C-terminal tip
134 These observations support a direct role for myosin-IIA heavy-chain phosphorylation in mediating moti
135 Cells expressing green fluorescent protein-myosin-IIA heavy-chain S1943E and S1943D mutants display
136 ith the immunologic synapse-related proteins myosin IIA, high mobility group box 1, and the TCR Vbeta
139 1 cells expressing green fluorescent protein-myosin IIA, immobilised on fibronectin micropatterns to
140 proposed convergence measure correlates with myosin IIa immuno-localization and is capable to resolve
142 genesis, and they establish a novel role for Myosin IIA in signal transduction events modulating VEGF
144 ggest that base-line expression of nonmuscle myosin IIA inhibits osteoclast precursor fusion and that
145 ied as an inhibitor that disrupts the S100A4/myosin-IIA interaction and inhibits S100A4-mediated depo
146 n in which phenothiazines disrupt the S100A4/myosin-IIA interaction by sequestering S100A4 via small
153 erform distinct cellular activities and that myosin IIA is preferentially required for Rho-mediated c
159 temporary, cathepsin B-mediated decrease in myosin IIA levels triggers precursor fusion during osteo
163 owed that B cells acquire antigen by dynamic myosin IIa-mediated contractions that pull out and invag
164 reating thrombi with blebbistatin to inhibit myosin IIa-mediated platelet contractility prevented shr
165 sin IIA function and that granule-associated myosin IIA mediates the interaction of granules with F-a
166 arity emerges from the cooperative effect of myosin IIA (MIIA) and IIB (MIIB) on adhesive signaling.
167 logic inhibition of myosin-II, but nonmuscle myosin-IIA (MIIA) mutations paradoxically cause MYH9-rel
171 imaging techniques demonstrated that single myosin IIA molecules associate with NK-cell lytic granul
172 metric levels, mts1 inhibits the assembly of myosin-IIA monomers into filaments and promotes the disa
173 -IIA filaments and inhibited the assembly of myosin-IIA monomers with maximal inhibition of assembly
176 main in chicken gizzard myosin and nonmuscle myosin IIA (MYH-9) but exhibit little binding to skeleta
178 eins include fodrin (nonerythroid spectrin), myosin-IIA, myosin-IG, alpha-actinin 1, alpha-actinin 4,
179 from patients with a truncation mutation in myosin IIA, NK cell cytotoxicity, lytic granule penetrat
181 e identify the heavy chain of the non-muscle myosin IIA (NMHC-IIA) as being phosphorylated in a speci
182 s in the S1943 phosphorylation of non-muscle Myosin IIA (NMIIA) heavy chain, thus facilitating NMIIA
183 dies initially focused on roles of nonmuscle myosin IIA (NMIIA) in the developing mouse epidermis, we
185 addition, MyoGEF co-localizes with nonmuscle myosin IIA (NMIIA) to the front of migrating cells, and
188 ell proliferation and identified nonmuscular myosin IIA (NMM-IIA) as a receptor required for binding
190 d the association of gelsolin with nonmuscle myosin IIA (NMMIIA) at collagen adhesions are regulated
191 s showed that FliI associated with nonmuscle myosin IIA (NMMIIA), which was confirmed by immunoprecip
192 Collapse is inhibited by overexpression of myosin IIA or growth on high substrate-bound laminin-1.
196 erfering RNA (siRNA)-mediated suppression of myosin IIA or myosin IIB causes an increase in mitochond
198 a disruption of podosome rosettes caused by myosin-IIA overassembly, and a myosin-independent increa
199 that interference with the putative Rho-ROCK-myosin-IIA pathway selectively decreases the number of c
202 ably through depletion of spindle-associated myosin IIA protein and antibody binding to chromosome su
204 ar myosin phosphatase complexes that include myosin IIA, protein phosphatase 1delta, and myosin phosp
205 ts in THP1 cells, whereas the suppression of myosin-IIA rescued podosome formation regardless of ARF1
208 Rac2 and Myosin 9 (Myh9), the heavy chain of Myosin IIA, resulting in augmented vascular endothelial
210 myosin, nonmuscle myosin IIB, and nonmuscle myosin IIA revealed three distinct regimes of behavior,
214 n flow, and depletion of myosin IIB, but not myosin IIA, showed similar nondirectional nuclear moveme
215 Similar to non-muscle myosin IIB, non-muscle myosin IIA shows high ADP affinity and little enhancemen
220 -Aldrich syndrome protein (WASp), actin, and myosin IIA that formed during NK cell activation was ide
221 Instead, we find that local inactivation of Myosin IIA, through a noncanonical Ser1/2 phosphorylatio
223 ibitory signal, the recruitment of actin and myosin IIA to a constitutive WIP-WASp complex was greatl
224 A response that involves loss of growth cone myosin IIA to facilitate actin meshwork instability and
225 hat monitors the Ca(2+)-dependent binding of myosin-IIA to S100A4, NSC 95397 was identified as an inh
227 n of endogenous HeLa cell BIG1 and BIG2 with myosin IIA was demonstrably independent of Arf guanine n
230 myosin IIB, but not anterior distribution of myosin IIA, was inhibited by dominant-negative rhoA and
231 ing NK cells from patients with mutations in myosin IIA, we found that the nonhelical tailpiece is re
234 On fibronectin, NGF caused inactivation of myosin IIA, which negatively regulated actin bundling.
235 yosin-like recombinant fragment of nonmuscle myosin IIA, which was expressed in baculovirus along wit
237 microM inhibited anterior redistribution of myosin IIA, with 100 microM blebbistatin causing posteri
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。